Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1487, 2005-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Budesonide/formoterol combo better than monotherapy in asthma
Inpharma, Vol. 1, Iss. 1581, 2007-01 ,pp. :
Access to resources
Recommend
Risperidone better value than olanzapine
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 261, 2000-01 ,pp. :
Temozolomide more cost effective than combo therapy in glioblastoma
Inpharma, Vol. 1, Iss. 1502, 2005-01 ,pp. :
Temozolomide more cost effective than combo therapy in glioblastoma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 485, 2005-01 ,pp. :
Fluticasone propionate better value than flunisolide in asthma
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 245, 2000-01 ,pp. :